clinicalresearch outsource clinicaltrials consulting research researchanddevelopment healthcare biotech pharma medicine oncology lifescience neurology autoimmune immunology clinical development clinical trial ClinicalResearchOrganisation cell therapy car-t cell therapy biotech biotechnology cancer research cancer immunology immunooncology immunotherapy collaboration CRO regulatory affairs

The Future for Clinical Research and Development in Germany

What’s Next ? Reduce dependencies, take more risks!

Prof. Bernd Raffelhüschen is a famous German economist who has been drawing attention to the demographic changes in Germany for years.  
In his lectures he often suggests and calls for a more independent position from the demographic problems in Germany.

In the scope of many conferences and network cooperations, REAgency+ is a representative for the promotion of young academics and a contact person for business advice and development in clinical research. In the interaction with young research academics, innovators and industry, there is a great demand for business and personal development opportunities, added value in collaboration and an effective value chain.

Bernd Raffelhüschen, for example, once recommended in one of his lectures to focus on future-relevant areas and to push the development of new industries and technologies. Economic growth should be supported and the quality of life in Germany improved.

Providing research funding, especially for areas relevant to the future, can help researchers develop their skills and expertise.
Above all, and REAgency+ is committed to and supports this approach, it is particularly important to promote a culture of innovation. Raffelhüschen suggests to be encouraged to take risks and explore new ideas.

International collaboration also creates opportunities for researchers to work with international partners.
Business entrepreneurship needs to be boosted and researchers need to be supported more. Start-ups and small businesses could be supported more by a supportive legal environment.

What is your opinion on the topic?

Here is one of the available lectures by Prof. Bernd Raffelhüschen

#clinicalresearch #outsource #clinicaltrials #consulting #research #researchanddevelopment #healthcare
#biotech #pharma #medicine #oncology #lifescience #neurology #autoimmune #immunology #clinicaldevelopment #clinicaltrial #ClinicalResearchOrganisation  #regulatoryaffairs #demographics #futureofhealthcare # #entrepreneurship #work #innovation #opportunities #funding #growth #future #development #academics #researchers